{"id":"https://openalex.org/W4404975663","doi":"https://doi.org/10.1158/1535-7163.27951057","title":"Figure S1 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity","display_name":"Figure S1 from Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity","publication_year":2024,"publication_date":"2024-12-03","ids":{"openalex":"https://openalex.org/W4404975663","doi":"https://doi.org/10.1158/1535-7163.27951057"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.27951057","doi":"https://doi.org/10.1158/1535-7163.27951057","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.27951057","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.27951057","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083063156","display_name":"Priyanka Shailendra Rana","orcid":"https://orcid.org/0000-0001-5774-4383","observed_orcids":["https://orcid.org/0000-0001-5774-4383"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Priyanka S. Rana","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5774-4383","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012867231","display_name":"James John Ignatz-Hoover","orcid":"https://orcid.org/0000-0001-8196-2655","observed_orcids":["https://orcid.org/0000-0001-8196-2655"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. Ignatz-Hoover","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8196-2655","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065393544","display_name":"Chunna Guo","orcid":"https://orcid.org/0000-0001-6075-7441","observed_orcids":["https://orcid.org/0000-0001-6075-7441"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chunna Guo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6075-7441","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059619254","display_name":"Amber L. Mosley","orcid":"https://orcid.org/0000-0001-5822-2894","observed_orcids":["https://orcid.org/0000-0001-5822-2894"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amber L. Mosley","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5822-2894","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083283435","display_name":"Ehsan Malek","orcid":"https://orcid.org/0000-0003-4719-4327","observed_orcids":["https://orcid.org/0000-0003-4719-4327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ehsan Malek","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4719-4327","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109734528","display_name":"Yuriy Federov","orcid":"https://orcid.org/0000-0001-9513-8341","observed_orcids":["https://orcid.org/0000-0001-9513-8341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuriy Federov","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9513-8341","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025223840","display_name":"Drew Adams","orcid":"https://orcid.org/0000-0002-3038-336X","observed_orcids":["https://orcid.org/0000-0002-3038-336X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Drew J. Adams","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3038-336X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5035898667","display_name":"James Joseph Driscoll","orcid":"https://orcid.org/0000-0001-8364-0617","observed_orcids":["https://orcid.org/0000-0001-8364-0617"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James J. Driscoll","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8364-0617","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.451200008392334,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.451200008392334,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.16089999675750732,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.056699998676776886,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoantigens","display_name":"neoantigens","score":0.968999981880188},{"id":"https://openalex.org/keywords/high-throughput-screening-hits","display_name":"high-throughput screening hits","score":0.6959999799728394},{"id":"https://openalex.org/keywords/hdac6-inhibitors","display_name":"HDAC6 inhibitors","score":0.9229999780654907},{"id":"https://openalex.org/keywords/tubastatin-a","display_name":"tubastatin A","score":0.8650000095367432},{"id":"https://openalex.org/keywords/acy-1215","display_name":"ACY-1215","score":0.9860000014305115}],"concepts":[{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.5621750950813293},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5560010075569153},{"id":"https://openalex.org/C2777212361","wikidata":"https://www.wikidata.org/wiki/Q5127848","display_name":"Class (philosophy)","level":2,"score":0.5325839519500732},{"id":"https://openalex.org/C2778814158","wikidata":"https://www.wikidata.org/wiki/Q959350","display_name":"MHC class II","level":4,"score":0.4792892336845398},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46767458319664},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40001487731933594},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3775967061519623},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35134953260421753},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.32689857482910156},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.30401426553726196},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2770470380783081},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2720481753349304},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1924661099910736},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.15675336122512817},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.15408045053482056},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.13545826077461243},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.27951057","doi":"https://doi.org/10.1158/1535-7163.27951057","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.27951057","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.27951057","doi":"https://doi.org/10.1158/1535-7163.27951057","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.27951057","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404975781","https://openalex.org/W7165036610","https://openalex.org/W7165005243","https://openalex.org/W4399760541","https://openalex.org/W4362524630","https://openalex.org/W4386271027","https://openalex.org/W4404976104","https://openalex.org/W4399793490","https://openalex.org/W4396924324","https://openalex.org/W4399772229"],"abstract_inverted_index":{"Figure":[0],"S1.":[1],"Chemical":[2],"structure":[3],"of":[4],"the":[5,14,21],"eight":[6],"hits,":[7],"designated":[8],"as":[9],"Compounds":[10],"A-H,":[11],"detected":[12],"in":[13],"high":[15],"throughput":[16],"screen.":[17],"Also":[18],"shown":[19],"are":[20],"known":[22],"HDAC6":[23],"inhibitors":[24],"tubastatin-A,":[25],"ACY-1215,":[26],"ACY-738,":[27],"and":[28],"nexturastat":[29],"A.":[30]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2024-12-04T00:00:00"}